For research use only. Not for therapeutic Use.
Tenofovir disoproxil（Cat No.:I002544）, also known as tenofovir disoproxil fumarate, is an antiretroviral agent used for the prevention and treatment of HIV/AIDS as well as the treatment of chronic hepatitis B. It belongs to the class of nucleotide reverse transcriptase inhibitors and works by inhibiting the reverse transcriptase enzyme necessary for viral replication. Tenofovir disoproxil is administered orally and is commonly included in combination therapy regimens for HIV/AIDS to suppress viral load, improve immune function, and reduce the risk of disease progression.
| Catalog Number | I002544 |
| CAS Number | 201341-05-1 |
| Molecular Formula | C19H30N5O10P |
| Purity | ≥95% |
| Solubility | DMSO ≥ 38 mg/mL |
| Storage | 2-8°C |
| IUPAC Name | [[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate |
| InChI | InChI=1S/C19H30N5O10P/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22)/t14-/m1/s1 |
| InChIKey | JFVZFKDSXNQEJW-CQSZACIVSA-N |
| SMILES | CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C |
| Reference | <p style=/line-height:25px/> |
